Hepion Pharmaceuticals (HEPA) Q1 2026 Earnings

14MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q1 2026
-0.07
0.26
0.6
0.93

Details

Expected EPS
N/A
Actual EPS
-0.07
Surprise EPS
-0.07
Surprise Percent
+∞%

Description

Hepion Pharmaceuticals (HEPA) has reported earnings of -0.07 per share for Q1 2026.

0 Comments

Share your thoughts